Stomach cancer rate set to fall further 25 percent over next decade

Aug 14, 2007

New cases of stomach cancer are set to plummet a further 25 per cent in the West over the next decade, indicates research published ahead of print in the journal Gut.

Stomach cancer is the fourth most common cancer, and the second leading cause of cancer related death, in the world.

The findings are based on the long term monitoring of the three types of cell changes indicative of subsequent stomach cancer.

The authors tracked all new cases of atrophic gastritis, intestinal metaplasia, and dysplasia recorded in the Dutch national registry of diseased tissue samples.

The monitoring period covered the years 1991 to 2005 and included almost 98,000 patients who had a routine tissue sample (biopsy) taken.

Most of the cases were intestinal metaplasia, which was diagnosed in almost 66,000 patients during the monitoring period.

The figures showed that the rate of new cases fell steadily by between 2.4 and 2.9% a year in women and men, respectively.

Dysplasia, which was diagnosed in just over 8500 patients, and atrophic gastritis, which was diagnosed in just over 23,000, both fell by more than 8% a year.

The fall in new cases of intestinal metaplasia and atrophic gastritis was even sharper after 1996, the figures showed.

On the basis of these trends, the authors calculate that new cases of gastric cancer will fall by “at least 24%” over the next decade in the West, without the need for treatment.

The authors say that the fall in the number of cases of gastric inflammation caused by Helicobacter pylori infection largely explains the figures.

Source: BMJ-British Medical Journal

Explore further: The fine line between breast cancer and normal tissues

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

The fine line between breast cancer and normal tissues

3 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

4 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

7 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

8 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments : 0